Drug reference
Patients with confirmed serogroup C disease (who have previously been immunised) ▶BY INTRAMUSCULAR INJECTION ▶Child 1–17 years: 0.5 mL for 1 dose, dose to be given before discharge from hospital ▶Adult 18–24 years: 0.5 mL for 1 dose, dose to be given before discharge from hospital
PDF page 1406
Available as part of childhood immunisation schedule from www.immform.dh.gov.uk.
PDF page 1407
▶Common or very common Anxiety (in children). cough (in children). crying (in children). drowsiness (in children). gastrointestinal discomfort (in children). hyperhidrosis (in children). increased risk of infection (in children) ▶Uncommon Chills. eyelid oedema (in children). flushing (in children). influenza like illness (rare in children). joint stiffness (in children) ▶Rare or very rare Circulatory collapse (in children) ▶Frequency not known Angioedema. apnoea. asthenia (uncommon in children). dyspnoea. hypotonic- hyporesponsiveness episode. immune thrombocytopenic purpura. meningism (but no evidence that vaccine causes meningococcal C meningitis). musculoskeletal stiffness (uncommon in children). nasal congestion (uncommon in children). oedema (uncommon in children). pain (very common in children). respiratory disorders (uncommon in children). seizures (uncommon in children). sensation abnormal (uncommon in children). sleep disorders (very common in children). Stevens-Johnson syndrome. syncope (uncommon in children)
PDF page 1406
There can be variation in the licensing of different medicines containing the same drug. Suspension for injection ▶NeisVac-C (Pfizer Ltd) NeisVac-C vaccine suspension for injection 0.5ml pre-filled syringes | 10 pre-filled disposable injection P £187.50 eiiii F 1379
PDF page 1407
0.5 mL for 1 dose, dose to be given
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1406
